Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERDAFITINIB vs ERENUMAB-AOOE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERDAFITINIB vs ERENUMAB-AOOE: Safety Overview

Metric ERDAFITINIB ERENUMAB-AOOE
Total FAERS Reports 1,106 50,133
Deaths Reported 315 1,935
Death Rate 28.5% 3.9%
Hospitalizations 226 3,054
Average Patient Age 66.6 yrs 50.2 yrs
% Female Patients 37.9% 86.2%
FDA Approval Date Apr 12, 2019 N/A
Manufacturer Janssen Products LP N/A
Route ORAL N/A
Marketing Status Prescription Prescription